Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Aerovate Therapeutics
200 Berkeley St 18TH FLOOR
Boston, MA 02116
Phone: 617-778-2494
https://www.aerovatetx.com/

Aerovate Therapeutics is a biotechnology company focused on developing drugs that meaningfully improve the lives of patients with rare cardiopulmonary disease. Aerovate's lead program is a potentially disease modifying drug, AV-101, for people who suffer from pulmonary arterial hypertension (PAH). AV-101 is a proprietary inhaled dry powder formulation of the drug imatinib that delivers this medicine directly to diseased lung tissues while reducing systemic adverse side effects. Aerovate was founded and incubated by RA Capital Management, a multi-stage investment manager focused on healthcare and life sciences.

Key Contact
Name
Benjamin T. Dake
Title
President
E-Mail
Funding Events

Date
Amount
Type
Investors
Valuation
08/07/20 $72,600,000 Series A Atlas Venture
Cormorant Asset Management
Osage University Partners
RA Capital Management
Sofinnova Partners
Surveyor Capital
undisclosed